Constellation Pharmaceuticals, Inc. logo
Constellation Pharmaceuticals, Inc. CNST

Constellation Pharmaceuticals, Inc. Retained Earnings 2011-2026 | CNST

Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.
Possible uses include
  • reinvestment in development (R&D, equipment, marketing)
  • debt repayment
  • acquisition of other companies
  • creation of reserves for the future

A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.

The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.

Annual Retained Earnings Constellation Pharmaceuticals, Inc.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-446 M -319 M -234 M -174 M -139 M - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-139 M -446 M -262 M

Retained Earnings of other stocks in the Biotechnology industry

Issuer Retained Earnings Price % 24h Market Cap Country
Aptorum Group Limited Aptorum Group Limited
APM
-73.8 M $ 0.87 -0.11 % $ 6.4 M chinaChina
Aquestive Therapeutics Aquestive Therapeutics
AQST
-447 M $ 4.18 1.95 % $ 447 M usaUSA
MorphoSys AG MorphoSys AG
MOR
-158 M - 2.43 % $ 254 M germanyGermany
Biohaven Pharmaceutical Holding Company Ltd. Biohaven Pharmaceutical Holding Company Ltd.
BHVN
-2.59 B $ 9.76 1.77 % $ 631 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
-63.5 M - -10.17 % $ 12.2 K usaUSA
BioNTech SE BioNTech SE
BNTX
-410 M $ 96.92 -6.31 % $ 27.2 B germanyGermany
I-Mab I-Mab
IMAB
-8.33 B - - $ 866 M chinaChina
Akero Therapeutics Akero Therapeutics
AKRO
-826 M - - $ 3.67 B usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
-122 M - -18.52 % $ 27.3 M britainBritain
AlloVir AlloVir
ALVR
-160 M - 4.14 % $ 49.1 M usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
5.24 B - - $ 40.3 B usaUSA
Biophytis SA Biophytis SA
BPTS
-17.1 M - -13.47 % $ 169 M franceFrance
Genfit SA Genfit SA
GNFT
-405 M - 2.54 % $ 160 B franceFrance
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
-2.2 B $ 21.99 -2.05 % $ 3.64 B usaUSA
Cerus Corporation Cerus Corporation
CERS
-1.08 B $ 2.89 42.45 % $ 551 M usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
-108 M - -1.52 % $ 24.7 M usaUSA
Athira Pharma Athira Pharma
ATHA
-512 M - - $ 269 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
-366 M - - $ 10.1 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
-149 M - - $ 7.46 M israelIsrael
AstraZeneca PLC AstraZeneca PLC
AZN
5.3 B - - $ 96.9 B britainBritain
Atreca Atreca
BCEL
-457 M - -11.76 % $ 5.79 M usaUSA
Berkeley Lights Berkeley Lights
BLI
-362 M - -7.31 % $ 87 M usaUSA
Calithera Biosciences Calithera Biosciences
CALA
-491 M - -10.95 % $ 876 K usaUSA
Advaxis Advaxis
ADXS
-197 M - -9.65 % $ 45.9 M usaUSA
CymaBay Therapeutics CymaBay Therapeutics
CBAY
-978 M - - $ 3.45 B usaUSA
ChemoCentryx ChemoCentryx
CCXI
-617 M - - $ 3.74 B usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
69.4 M - - - russiaRussia
Caladrius Biosciences Caladrius Biosciences
CLBS
-548 M - -16.75 % $ 25.8 M usaUSA
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
-201 M - - $ 231 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
-335 M - 5.93 % $ 314 M canadaCanada
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
-237 M - -2.5 % $ 5.88 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
-1.13 B - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
-308 M - - $ 26.5 M usaUSA
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
-1.43 B - - $ 2.18 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
-268 M - 1.93 % $ 17.4 M usaUSA
Innate Pharma S.A. Innate Pharma S.A.
IPHA
-220 M $ 1.44 - $ 235 M franceFrance
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
-903 M - - $ 2.02 B usaUSA
Akouos Akouos
AKUS
-168 M - 0.23 % $ 488 M usaUSA
Allakos Allakos
ALLK
-1.12 B - - $ 28.6 M usaUSA
Editas Medicine Editas Medicine
EDIT
-1.63 B $ 2.88 -4.17 % $ 256 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
-176 M $ 2.97 -6.9 % $ 4.89 M israelIsrael
Edesa Biotech Edesa Biotech
EDSA
-58.6 M $ 18.1 -0.96 % $ 57.9 M usaUSA
Eiger BioPharmaceuticals Eiger BioPharmaceuticals
EIGR
-512 M - -9.21 % $ 2.55 M usaUSA
Eloxx Pharmaceuticals Eloxx Pharmaceuticals
ELOX
-274 M - -5.68 % $ 8.28 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
-1.06 B - - $ 867 M germanyGermany
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
-243 M - -11.43 % $ 502 K usaUSA
Applied Therapeutics Applied Therapeutics
APLT
-469 M - - $ 8.42 M usaUSA
Evogene Ltd. Evogene Ltd.
EVGN
-179 M $ 0.8 2.56 % $ 27.9 M israelIsrael
Aptose Biosciences Aptose Biosciences
APTO
-566 M - -45.71 % $ 1.2 M canadaCanada